Patents by Inventor Richard Green

Richard Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9783175
    Abstract: A cable mounting assembly that may include a ball fitting having a hole that receives a cable assembly. The ball fitting may be disposed in an abutment and may be received in a bracket that may be disposed on the abutment.
    Type: Grant
    Filed: February 18, 2013
    Date of Patent: October 10, 2017
    Assignee: Ford Global Technologies, LLC
    Inventors: Joseph L Buchwitz, James Adam Drozdowski, Andrew Arthur Brown, Jacob Peter Stencel, Mason Otto Suksumake, Richard Green
  • Publication number: 20170268537
    Abstract: A circular row of non-uniformally spaced vanes includes only one first group and only one second group of adjacent vanes, unequal first and second spacing between adjacent vanes in the first and second groups, and first spacing greater than second spacing. An embodiment with second group including only three adjacent vanes. Second spacing may be about 25%-35% smaller than a nominal uniform spacing used as a design parameter for designing spacing of the non-uniformly spaced stator vanes. Circular row may be sectored. A gas turbine engine section may include one or more rings or circular rows of fixed and/or variable non-uniformally spaced vanes. Method for designing non-uniform vane spacing for circular row includes determining nominal uniform spacing and forming first spacing and second spacing from nominal uniform spacing of vanes.
    Type: Application
    Filed: March 15, 2016
    Publication date: September 21, 2017
    Inventors: Mark Joseph Mielke, Peter John Wood, Brian Richard Green, Steven Mitchell Taylor, Curtis Moeckel, Mark Joseph Frisch, Joseph Michael Bruni
  • Publication number: 20170240905
    Abstract: Connexin modulation for the treatment of wounds that do not heal at expected rates, including delayed healing wounds, incompletely healing wounds, and chronic wounds, and associated methods, compositions and articles.
    Type: Application
    Filed: May 1, 2017
    Publication date: August 24, 2017
    Inventors: David L. BECKER, Colin Richard GREEN, Bradford J. DUFT
  • Patent number: 9738892
    Abstract: Treatment of fibrosis and fibrotic diseases, disorders, and conditions, and associated methods, compositions, formulations and articles.
    Type: Grant
    Filed: March 9, 2015
    Date of Patent: August 22, 2017
    Assignee: CODA THERAPEUTICS, INC.
    Inventors: David Lawrence Becker, Colin Richard Green, Bradford James Duft
  • Publication number: 20170165435
    Abstract: An air removal device for an intravenous fluid system includes a housing with an inlet for fluid communication with a fluid source, a fluid outlet for fluid communication with a blood vessel of a patient, and an air outlet. The air removal device further includes a disrupting element disposed within the housing in a flow path between the inlet and the fluid outlet, and an air chamber in fluid communication with the air outlet. The disrupting element includes a protrusion extending across the flow path. The flow path includes a first cross-sectional flow area at the inlet, and a second cross-sectional flow area at the protrusion. The second cross-sectional flow area is smaller than the first cross-sectional flow area.
    Type: Application
    Filed: February 14, 2014
    Publication date: June 15, 2017
    Inventor: Richard Green
  • Publication number: 20170121746
    Abstract: A method of making nicotinamide riboside, nicotinamide riboside derivatives, or mixtures thereof is disclosed. The method involves contacting at least the following materials to form a solution: i) ?-D-ribose-1-phosphate, ?-D-ribose-1-phosphate derivatives, or mixtures thereof; ii) nicotinamide, nicotinamide derivatives, or mixtures thereof; iii) one or more pentosyl transferases (E.C. 2.4.2); iv) and one or more solvents. The resulting solution comprises nicotinamide riboside, nicotinamide riboside derivatives, or mixtures thereof and one or more inorganic orthophosphate anions. The inorganic orthophosphate anions are removed from the solution, leaving a solution of nicotinamide riboside, nicotinamide riboside derivatives, or mixtures thereof.
    Type: Application
    Filed: October 18, 2016
    Publication date: May 4, 2017
    Inventors: Juan Esteban Velasquez, Phillip Richard Green, John August Wos
  • Publication number: 20170126984
    Abstract: A telescope remote display and control system for viewing objects through a telescope and controlling the telescope remotely includes a wearable display, a manual controller, a camera, an mechanical adjuster, and an integration system, all of which are electrically interconnected. In the preferred embodiment, the camera, mechanical adjuster, and integration system are all attached to a target telescope and tripod assembly, while the wearable display and manual controller are positioned remotely. The integration system operates as the control hub, allowing a user to view images from the telescope with the wearable display by way of signals from the camera and control the positioning of the telescope with the manual controller through manipulation of the mechanical adjuster.
    Type: Application
    Filed: October 29, 2015
    Publication date: May 4, 2017
    Inventor: Richard Green
  • Patent number: 9637745
    Abstract: Connexin modulation for the treatment of wounds that do not heal at expected rates, including delayed healing wounds, incompletely healing wounds, and chronic wounds, and associated methods, compositions and articles.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: May 2, 2017
    Assignee: CoDa Therapeutics, Inc.
    Inventors: David Lawrence Becker, Colin Richard Green, Bradford James Duft
  • Publication number: 20170094556
    Abstract: Methods, systems, and apparatuses are described for adaptive dwell time for scan procedures. A wireless station (STA) may identify a scan period during which a passive scan procedure is performed on a first channel. The STA may analyze a channel congestion metric during at least a portion of the scan period. The STA may transition from the passive scan procedure to an active scan procedure on the first channel during the scan period based at least in part on the analyzed channel congestion metric.
    Type: Application
    Filed: September 25, 2015
    Publication date: March 30, 2017
    Inventors: Sandip HomChaudhuri, Pradeep Kumar Yenganti, Michael Richard Green, Alireza Raissinia, Srinivas Katar, Hoon Ki Lee
  • Publication number: 20170094651
    Abstract: A method, an apparatus, and a computer-readable medium for wireless communication are provided. In one aspect, an apparatus is configured to determine whether radar signals are present on one or more channels. The apparatus is configured to transmit a channel feedback report that includes channel information for each of the one or more channels based on the determination of whether radar signals are present on the one or more channels. The channel information for each of the one or more channels includes at least one of a time at which radar signal detection was attempted, a frequency range of a detected radar signal, a set of radar signal characteristics, a received radar vector, a geographical location of the wireless device when radar signal detection was attempted, or an indication of wireless activity.
    Type: Application
    Filed: September 24, 2015
    Publication date: March 30, 2017
    Inventors: Michael Richard GREEN, John FORRESTER
  • Patent number: 9561311
    Abstract: Medical devices comprising an anti-connexin agent suitable for introduction into a subject.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: February 7, 2017
    Assignee: CoDA Therapeutics, Inc.
    Inventors: David Lawrence Becker, Colin Richard Green, Bradford James Duft
  • Publication number: 20170034707
    Abstract: Methods, systems, and apparatuses are described for wireless communications. More particularly, an access point may assign a channel weighting factor to each channel in a candidate channel list. The access point may identify an attribute of a radar signal detected on a current operating channel. The access point may adjust, based at least in part on the identified attribute, the channel weighting factor assigned to a channel of the candidate channel list adjacent to the current operating channel. The access point may select a new operating channel from the candidate channel list based at least in part on the assigned channel weighting factor.
    Type: Application
    Filed: July 27, 2015
    Publication date: February 2, 2017
    Inventors: Michael Richard Green, Meriam Rezk, Youhan Kim, Mahboobul Alem
  • Publication number: 20160331805
    Abstract: Methods and compositions for modulating the activities of connexins are provided, including, for example, for use for treatment of cardiovascular, vascular, neurological, for wounds and for other indications. These compounds and methods can be used therapeutically, for example, to reduce the severity of adverse effects associated diseases and disorders where localized disruption in direct cell-cell communication or prevention of hemichannel opening is desirable.
    Type: Application
    Filed: February 1, 2016
    Publication date: November 17, 2016
    Inventors: Colin Richard GREEN, David Lawrence BECKER
  • Publication number: 20160243015
    Abstract: Desired skin colour is a major unmet consumer need around the world and especially in Asia. Consumers particularly desire even skin colour, absence of age spots (solar lentigines), absence of hyperpigmentation and lighter overall skin tone. One solution is to use biological actives that reduce the activity of melanocyte cells in skin. These cells, present in the basal layer of the epidermis, make the dark coloured pigment melanin and export it, in small export vesicles called melanosomes, to the neighbouring keratinocytes. It is well described in the literature that compounds which reduce melanin synthesis when topically applied to the skin will reduce skin darkness over time and can generate a more even skin tone. Tyrosinase is a very popular target for the regulation of melanocyte pigment production. However effective inhibitors of tyrosinase are bedevilled by safety issues causing, for example, melanocyte cell death, permanent depigmentation, irritation and allergic reactions.
    Type: Application
    Filed: October 14, 2014
    Publication date: August 25, 2016
    Applicant: Conopco, Inc., d/b/a UNILEVER
    Inventors: Martin Richard GREEN, Rebecca Susan GINGER, Robert Charles GLEN
  • Patent number: 9399951
    Abstract: Louver systems for gas turbine bleed air systems are disclosed. An example louver system may include a bleed system discharge opening arranged to vent bleed air from a bleed flow conduit and a plurality of pivotable louvers disposed proximate the discharge opening, the pivotable louvers being pivotable between a shut position and an open position. In the shut position, individual louvers may at least partially obstruct the discharge opening. In the open position, individual louvers may at least partially control a direction of flow of the bleed air exiting the discharge opening.
    Type: Grant
    Filed: April 17, 2012
    Date of Patent: July 26, 2016
    Assignee: General Electric Company
    Inventors: Christina Granger Morrissey Haugen, Bradley Willis Fintel, Brian Richard Green, Kevin Samuel Klasing
  • Publication number: 20160177298
    Abstract: The inventions relate to compositions and articles of manufacture comprising connexin modulators, pannexin modulators, gap junction modulators, hemichannel modulators, and pannexin channel modulators and their use, alone or in combination, in treating ocular and other disorders.
    Type: Application
    Filed: August 21, 2015
    Publication date: June 23, 2016
    Inventors: Colin Richard GREEN, Yeri KIM, Anthony PHILLIPS, Bradford James DUFT
  • Patent number: 9365446
    Abstract: Methods for processing glass using select wavelength radiation in a convective environment, broadly referred to as “Local Temporary Annealing”, “LASER Edge Strengthening” and “LASER Enhanced Thermal Strengthening.” Local Temporary Annealing allows strengthened glass to be brought to a neutral stress state so daughter units can be cut from strengthened glass and other processes usually only performed on annealed glass. LASER Edge Strengthening allows surface compression to be thermally imparted to the edges of a whole sheet or daughter units cut from annealed glass, or modification of residual edge stress profiles in strengthened glass to produce stable, strengthened edges. LASER Enhanced Thermal Strengthening allows surface compression to be imparted to a sheet of annealed glass whilst maintaining reduced surface temperatures so the glass has superior geometric stability and surface compression can be imparted at levels not conventionally possible.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: June 14, 2016
    Inventor: Richard Green
  • Publication number: 20160160214
    Abstract: A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decrease of scar formation and skin rejuvenation and thickening.
    Type: Application
    Filed: November 24, 2015
    Publication date: June 9, 2016
    Inventors: David Lawrence Becker, Colin Richard Green
  • Patent number: 9193754
    Abstract: A therapeutic and/or cosmetic formulation comprising at least one anti-sense polynucleotide to a connexin protein together with a pharmaceutically acceptable carrier or vehicle is useful in site specific down regulation of connexin protein expression, particularly in reduction of neuronal cells death, wound healing, reduction of inflammation, decrease of scar formation and skin rejuvenation and thickening.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: November 24, 2015
    Assignee: CoDa Therapeutics, Inc.
    Inventors: David Lawrence Becker, Colin Richard Green
  • Patent number: D774181
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: December 13, 2016
    Inventor: Richard Green